Abstract
Pheochromocytoma is an infrequent secondary cause of arterial hypertension, often associated with paroxysmal headache, sweating, weight loss, and palpitations. Cardiovascular complications of pheochromocytoma include sudden death, heart failure due to toxic cardiomyopathy, and hypertensive encephalopathy. Here we report the case of a female with an acquired long-QT-syndrome as a rare complication of an extra-adrenal pheochromocytoma. Diagnosis was made after sotalol-induced Torsades de Pointes.
Similar content being viewed by others
Article PDF
References
Kääb S, Hinterseer M, Nabauer M, Steinbeck G : Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome—a case-control pilot study using i.v. sotalol. Eur Heart J 2003; 24: 649–657.
Ackerman MJ : Cardiac channelopathies: it's in the genes. Nat Med 2004; 10: 463–464.
Whalen RK, Althausen AF, Daniels GH : Extra-adrenal pheochromocytoma. J Urol 1992; 147: 1–10.
Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS : Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001; 134: 315–329.
Anderson GH Jr, Blakeman N, Streeten DH : The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 1994; 12: 609–615.
Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T : Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004; 27: 193–202.
Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW : Secondary hypertension in a blood pressure clinic. Arch Intern Med 1987; 147: 1289–1293.
Lenders JW, Eisenhofer G, Mannelli M, Pacak K : Phaeochromocytoma. Lancet 2005; 366: 665–675.
Bravo EL, Tagle R : Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 2003; 24: 539–553.
Eisenhofer G, Bornstein SR, Brouwers FM, et al: Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 2004; 11: 423–436.
Kihara H, Terai H, Kihara Y, et al: Pheochromocytoma of the left retroperitoneal paraganglion associated with torsade de pointes: a case report. J Cardiol 1997; 30: 37–44.
Shimizu K, Miura Y, Meguro Y, et al: QT prolongation with torsade de pointes in pheochromocytoma. Am Heart J 1992; 124: 235–239.
Sani IM, Solomon DS, Imhogene OA, Ahmad AM, Bala GS : QT dispersion in adult hypertensives. J Natl Med Assoc 2006; 98: 631–636.
Roshan J, George OK, Vineet S, George PV, Jose VJ : Torsade de pointes in a case of pheochromocytoma—an unusual presentation of an uncommon disease. Indian Heart J 2004; 56: 248–249.
Stenström G, Swedberg K : QRS amplitudes, QTc intervals and ECG abnormalities in pheochromocytoma patients before, during and after treatment. Acta Med Scand 1988; 224: 231–235.
Roden DM : Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350: 1013–1022.
Roden DM : Taking the “idio” out of “idiosyncratic”: predicting torsades de pointes. Pacing Clin Electrophysiol 1998; 21: 1029–1034.
Nabauer M, Kääb S : Potassium channel down-regulation in heart failure. Cardiovasc Res 1998; 37: 324–334.
Vos MA, de Groot SH, Verduyn SC, et al: Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation 1998; 98: 1125–1135.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Methe, H., Hinterseer, M., Wilbert-Lampen, U. et al. Torsades de Pointes: A Rare Complication of an Extra-Adrenal Pheochromocytoma. Hypertens Res 30, 1263–1266 (2007). https://doi.org/10.1291/hypres.30.1263
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.30.1263
Keywords
This article is cited by
-
Echocardiac features simulating hypertrophic obstructive cardiomyopathy in a patient with pheochromocytoma
Clinical Research in Cardiology (2009)
